Global Digital Pathology Market Is Likely To Grow At A CAGR Value Of Around 12.8% By 2028

The global digital pathology market was worth around USD 725.10 million in 2021 and is estimated to grow to about USD 1493.66 million by 2028, with a compound annual growth rate (CAGR) of approximately 12.8 percent over the forecast period. The report analyzes the Digital Pathology market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the Digital Pathology market.

Digital Pathology is crucial and efficient way of managing pathology so as to avoid human errors and cross-contamination of certain elements. The pandemic of 2020 bolstered the demand for Digital Pathology and is expected to have a bright outlook over the forecast period as well.

Rapid advancements in Digital Pathology technologies, increasing demand for better diagnostics, rising instances of chronic infectious diseases, and increasing use of technology in laboratories to advance testing and result time are some major factors that propel the Digital Pathology market potential over the forecast period.

The high cost of Digital Pathology is a major factor that is restraining the market potential on a global scale and is one that will have a negative impact on overall growth. Another factor that could hinder growth is lack of skilled professionals for Digital Pathology. These factors could hamper the growth through 2028 and Digital Pathology companies are focusing on solving these issues to enable Digital Pathology market growth at full potential.

The Digital Pathology market was one of the rare markets which saw an increase in demand in 2020 as coronavirus infections plagued the world. This led to a stable growth curve for the Digital Pathology market in 2020 while other markets toppled and barely managed to survive in the lockdown restrictions that were prevalent across the world.

Conventional pathology put healthcare professionals and pathologists at risk and even risked the cross-contamination of samples and digital pathology solved all of these issues hence seeing a rise in demand in face of adversity.

The demand for Digital Pathology is expected to have a dominant outlook in the post-pandemic era, as well as the use of healthcare technology, substantially increases through 2028. The Digital Pathology market will see high demand as healthcare spending increases across the world.

Browse the full “Digital Pathology Market By Product (Scanners, Software, Communication Systems, Storage Systems), By Type (Human Pathology, Veterinary Pathology), By Application (Drug Discovery, Disease Diagnosis, Teleconsultation, Training & Education), By End User (Pharmaceutical & Biotechnology Companies, Hospitals and Reference Laboratories, Academic & Research Institutes) and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/digital-pathology-market

The global Digital Pathology market is segregated based on type, product type, application, end user, and region. Based on application, the global market is distinguished into Drug Discovery, Disease Diagnosis, Teleconsultation, and Training & Education. The drug discovery segment is projected to emerge as the dominant segment and is anticipated to hold a major market share by the end of the forecast period. Increasing research and development for new drugs and the rising use of technologies to ensure faster drug development is expected to fuel the adoption of digital pathology in drug discovery over the forecast period.

North America holds a major market share in the global Digital Pathology marketplace and is expected to maintain this stance over the forecast period as well. The presence of developed healthcare infrastructure and the early adoption of novel technologies is anticipated to drive the Digital Pathology market potential in this region through 2028. The United States is anticipated to be the most prominent market in this region owing to rising healthcare expenditure and a growing patient pool. Increasing adoption of technology in healthcare, favorable reimbursement policies, and increasing research and development activities are expected to primarily drive the Digital Pathology market growth in North America.

Key players functioning in the global Digital Pathology market include Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), and Hamamatsu Photonics K.K. (Japan), Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain).

Recent developments:

• In August 2021, Sectra AB a Swedish company focused on medical technology signed an agreement with University Medical Center Utrecht (Netherlands) to use Sectra’s pathology module for discussions between radiologists and pathologists working at the University Medical Center Utrecht.

Global Digital Pathology market is segmented as follows:

By Product

• Scanners
• Software
• Communication Systems
• Storage Systems

By Type

• Human Pathology
• Veterinary Pathology

By Application

• Drug Discovery
• Disease Diagnosis
• Teleconsultation
• Training & Education

By End User

• Pharmaceutical & Biotechnology Companies
• Hospitals and Reference Laboratories
• Academic & Research Institutes

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com